Mr Alexandar Dukanovic
Gentofte University Hospital, Copenhagen (Denmark)
Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: A Danish nationwide cohort study.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
Non-vitamin K antagonist oral anticoagulants according to predicted risk of stroke and bleeding among patients with atrial fibrillation: Danish nationwide time trends 2011-2015
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation
ESC 365 is supported by
